ライフサイエンスコーパス: syngenic

1 Syngenic and allogeneic corneal tissues deprived of epit

2 rtening did not differ between nonrejecting, syngenic and rejecting, allogenic transplants.

3 and infect tumor and metastases is proven in syngenic and transplanted tumors in different animal mod

4 Using a variety of syngenic and xenograft models, we demonstrate here that

5 When transplanted in a syngenic animal pretreated with RS, rAECs were able to e

6 lateral limb ischemia, bone marrow MNCs from syngenic B(2)R-deficient mice resulted in reduced homing

7 o day 7 s.c. CMS4 sarcoma lesions growing in syngenic BALB/c mice, DC.mTbets dramatically slowed tumo

8 verexpressing Renca cells were injected into syngenic BALB/c mice, there was a consistent and signifi

9 n ventricular myocytes freshly isolated from syngenic (Balb/C into Balb/C) and allogenic (Balb/C into

10 In this study, we show that, following syngenic BMT, the in vivo administration of rIL-7/HGFbet

11 on of human ES-2 ovarian cancer cells, and a syngenic C57BL/6 model, established by i.p. inoculation

12 rmal CD40L exons 2-5 and was administered to syngenic CD40L-knockout mice.

13 ansplantation is depressed to 40% of that of syngenic controls, and that this depression of function

14 ain (DA) to Wistar furth rat strain rats and syngenic DA-DA grafts were used as controls.

15 Syngenic DBA/2 tumor-bearing mice treated with HSV-1 171

16 A suppresses S91 melanoma growth in vivo, in syngenic DBA2 mice.

17 s followed by grafts to the lesion cavity of syngenic fibroblasts genetically modified to secrete hig

18 When DBA/2 mice syngenic for the tumor were depleted of leukocytes by cy

19 derived from TGFbeta3 null mutant mice into syngenic hosts resulted in a significant inhibition of c

20 dels of breast cancer were utilized: namely, syngenic inbred Lewis female rats bearing the rat mammar

21 Orthotopic syngenic intestinal transplantation was performed in Lew

22 Orthotopic left LTxs were performed in syngenic Lewis rats.

23 These T cells lyse parasite-infected syngenic macrophages.

24 syngenic mice injected with three different syngenic mammary tumor cell lines that differ in their m

25 stration of 1 to Balb/C mice inoculated with syngenic meth/A cells demonstrated statistically signifi

26 suppress both s.c. implanted TRAMP tumors in syngenic mice as well as orthotopic prostate cancers in

27 e growth of primary tumors and metastasis in syngenic mice by inhibiting the catalytic activity of CD

28 ) interface versus the tumor alone area from syngenic mice injected with three different syngenic mam

29 ore aggressive behavior of tumors growing in syngenic mice, leading to enhanced local invasion into t

30 CCVII tumors that had been preestablished in syngenic mice, resulting in significant prolongation of

31 llantoic membranes of chicken embryos and in syngenic mice.

32 Experiments carried out in a mouse syngenic model demonstrated high antitumor activity of 4

33 nd differentiate upon transplantation into a syngenic model of liver repopulation.

34 hat studies in mouse models claimed that the syngenic mouse iPSC lines can be immunogenic.

35 in allogenic myocytes, but had no effect in syngenic myocytes.

36 or fatty rat livers, and an in vivo model of syngenic orthotopic liver transplants in rats.

37 In a syngenic orthotopic transplantation model, Prdx4 knockdo

38 Using virgin inbred mice undergoing a first syngenic pregnancy, in which only the male fetuses are a

39 Syngenic primary rat fibroblasts genetically modified to

40 nd the effect of preservation solutions in a syngenic rat hindlimb transplant model.

41 t MAA can be adoptively transferred to naive syngenic rats by MAA-primed T cells.

42 kDa) can be adoptively transferred to naive syngenic rats by primed CD4(+) T cells.

43 sease can be adoptively transferred to naive syngenic rats by primed CD4+ T cells.

44 anti-factor B did not transfer EAAU to naive syngenic rats.

45 in response to hormonal induction; otherwise syngenic RB-/- fibroblasts cultured in identical conditi

46 ntestinal organoid units were implanted into syngenic recipient rats.

47 e to euglycemia was significantly shorter in syngenic recipients of BSA/D than DA islets (5.7 +/- 4.8

48 plastic mammary ducts when transplanted into syngenic recipients, whereas cells from Atm(+/+) mice we

49 del was established following inoculation of syngenic SP2/0 cells stably transfected with NS5.

50 d box homeotic gene 3 (PAX3) locus, a region syngenic to mouse chromosome 1.

51 Allogenic and syngenic transplantation activate the HCMV IE enhancer t

52 kidneys but not significantly different from syngenic transplanted D(5)(-/-) mice, indicating the imp

53 d in C57Bl/6 by intraperitoneal injection of syngenic tumor cells (MC38).

54 e antigen-specific rejection of transplanted syngenic tumor cells.

55 was demonstrated by inoculating mice with a syngenic tumor expressing high levels of human ErbB-2.

56 tic tumor burden in orthotopic xenograft and syngenic tumor models, induced regression of established

57 Syngenic TWIST1-positive colon carcinoma cells (CT26) th

58 ) mice and radiation chimeras engrafted with syngenic VIP-KO hematopoietic cells.

59 ons of bone marrow reconstitution, including syngenic, were conducted between the congenic B6 and B6.